No abstract available
Keywords:
Diabetes; Diarrhea; Enteric nervous system; Motility.
MeSH terms
-
Antidiarrheals / therapeutic use
-
Autonomic Nervous System Diseases / etiology
-
Autonomic Nervous System Diseases / physiopathology*
-
Blind Loop Syndrome / diagnosis
-
Celiac Disease / diagnosis
-
Diabetes Mellitus, Type 1 / complications
-
Diabetes Mellitus, Type 1 / physiopathology*
-
Diabetes Mellitus, Type 2 / complications
-
Diabetes Mellitus, Type 2 / physiopathology*
-
Diabetic Neuropathies / etiology
-
Diabetic Neuropathies / physiopathology*
-
Diagnosis, Differential
-
Diarrhea / diagnosis
-
Diarrhea / drug therapy
-
Diarrhea / etiology
-
Diarrhea / physiopathology*
-
Diphenoxylate / therapeutic use
-
Enteric Nervous System / physiopathology*
-
Exocrine Pancreatic Insufficiency / diagnosis
-
Gastrointestinal Agents / therapeutic use
-
Gastrointestinal Motility / physiology
-
Hypoglycemic Agents / adverse effects
-
Imidazoles / therapeutic use
-
Inflammation
-
Inflammatory Bowel Diseases / diagnosis
-
Interstitial Cells of Cajal
-
Intestinal Absorption / physiology
-
Intestinal Mucosa
-
Irritable Bowel Syndrome / diagnosis
-
Loperamide / therapeutic use
-
Neuroglia
-
Non-Nutritive Sweeteners / adverse effects
-
Oxidative Stress / physiology
-
Phenylalanine / analogs & derivatives
-
Phenylalanine / therapeutic use
-
Serotonin 5-HT3 Receptor Antagonists / therapeutic use
Substances
-
Antidiarrheals
-
Gastrointestinal Agents
-
Hypoglycemic Agents
-
Imidazoles
-
Non-Nutritive Sweeteners
-
Serotonin 5-HT3 Receptor Antagonists
-
eluxadoline
-
Phenylalanine
-
Loperamide
-
Diphenoxylate